Recent Updates
Recently added Catalysts
LNTH Positive Sentiment Score: 75/100

Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

Tuesday, March 5, 2024 1 min read
Key Takeaway: Lantheus Holdings, Inc. announced that President Paul Blanchfield will present at the Leerink Partners Global Biopharma Conference 2024 on March 12, 2024. This event showcases the company's ongoing commitment to delivering radiopharmaceutical solutions. The presentation is intended to inform investors and stakeholders about Lantheus's advancements in disease management. A live webcast will be available, with a replay accessible for 30 days post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is presenting at a significant industry conference.
  • The company is a leader in the radiopharmaceutical sector.
  • The presentation highlights their commitment to improving patient outcomes.

Full Press Release Details

BEDFORD, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Paul Blanchfield, President, will present at the Leerink Partners Global Biopharma Conference 2024 at 9:20 a.m. ET on Tuesday, March 12.
To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.
Vice President, Investor Relations
Senior Director, External Communications

Frequently Asked Questions

When will Lantheus present at the Leerink Partners Conference?

Lantheus will present on March 12, 2024, at 9:20 a.m. ET.

How can I access the Lantheus presentation webcast?

Visit the Investors section of Lantheus's website to access the live webcast.

How long will the webcast replay be available?

The webcast replay will be available for at least 30 days after the live event.

What is Lantheus's focus as a company?

Lantheus focuses on radiopharmaceuticals to enhance disease detection and treatment.

Where is Lantheus headquartered?

Lantheus is headquartered in Bedford, Massachusetts.

Tags: LNTH Viatris Investor Conferences Healthcare Lantheus biopharma conference radiopharmaceuticals patient outcomes Paul Blanchfield
Last updated: Mar 5, 2024